Notably, some of the genes that make up replisome were upregulated in treatment failure patients with SCLC, e.g., cell division cycle 7 (CDC7), cell division cycle 45 (CDC45), MCM2, MCM4, MCM6, and MCM7. Control of replisome is an important concept in cancer treatment. This evidence concerns the gene MCM4 and small cell lung carcinoma.